Company: CMND
Filing Date: 2025-09-19
Form Type: F-1
Source: 0001213900-25-089545
Chunk: 42

Company: Clearmind Medicine Inc.
Filing Date: 2025-09-19
Form: F-1
Chunk 42
---
 Daniel N. Bloch.
Certain matters of U.S. federal law will be passed upon for us by Greenberg Traurig, P.A., Tel Aviv, Israel.

<div align='center'>25

EXPERTS</div>

The financial statements of
Clearmind Medicine Inc. as of October 31, 2024 and 2023 and for the years then ended, as included in this prospectus, have been audited
by Brightman Almagor Zohar & Co., a firm in the Deloitte global network, an independent registered public accounting firm, as stated
in their report. Such financial statements are included in reliance upon the report of such firm given the firm’s authority as experts
in accounting and auditing.

The audit report covering
the October 31, 2024 consolidated financial statements contains an explanatory paragraph that states that the Company’s recurring
losses from operations and lack of sufficient resources raise substantial doubt about the entity’s ability to continue as a going
concern. The consolidated financial statements do not include any adjustments that might result from the outcome of that uncertainty.

<div align='center'>ENFORCEMENT OF CIVIL LIABILITIES</div>

We are incorporated under
the laws of British Columbia. Some of our directors and officers, and some of the experts named in this prospectus, are residents of Canada
or otherwise reside outside of the United States, and all or a substantial portion of their assets, and all or a substantial portion of
our assets, are located outside of the United States. We have appointed an agent for service of process in the United States, but it may
be difficult for shareholders who reside in the United States to effect service within the United States upon those directors, officers
and experts who are not residents of the United States. It may also be difficult for shareholders who reside in the United States to realize
in the United States upon judgments of courts of the United States predicated upon our civil liability and the civil liability of our
directors, officers and experts under the United States federal securities laws. There can be no assurance that U.S. investors will
be able to enforce against us, members of our Board, officers or certain experts named herein who are residents of Canada or other countries
outside the United States, any judgments in civil and commercial matters, including judgments under the federal securities laws. There
can be no assurance that U.S. investors will be able to enforce against us, members of our Board, officers or certain experts named herein